BSE filing, NSE: VENMAX. Summary written from the filing by ALFA Finder's alert engine.
Venmax Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹13.39
- Market cap
- ₹11.76 Cr
- Revenue (annual)
- ₹8.02 Cr
- Net profit (annual)
- ₹0.25 Cr
- P/E (TTM)
- 42.0×Sector 45.9×
- Promoter holding
- 10.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Venmax Drugs & Pharmaceuticals Ltd
All →Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs' shareholders met on 24 October 2026 under an NCLT order to approve an amalgamation with Hatri Pharma. Voting results await the scrutinizer's report.
Venmax Drugs & Pharmaceuticals Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Venmax Drugs & Pharmaceuticals Acquisition
Venmax Drugs and Pharmaceuticals Limited announced an NCLT-convened meeting of equity shareholders on October 24, 2026, to consider the proposed merger with Hatri Pharma Private Limited.
Venmax Drugs & Pharmaceuticals Acquisition
NCLT Hyderabad directed Venmax to convene a shareholder meeting on 24 Oct 2026 for the amalgamation of Hatri Pharma into Venmax. The order also dispensed with meetings of Hatri Pharma's shareholders and creditors.
Venmax Drugs & Pharmaceuticals Annual Report
Venmax Drugs and Pharmaceuticals Limited has submitted its Annual Report for the Financial Year 2025-26, including the Notice for its 37th Annual General Meeting.
Venmax Drugs & Pharmaceuticals Board Meeting Outcome
Venmax Drugs held a board meeting to approve the Directors' Report, AGM date, and appoint/regularize key directors. The meeting outcomes were disclosed under Regulation 30.
Other annual general meeting announcements
All →Cedaar Textile Annual General Meeting
Cedaar Textile filed the summary of proceedings of its 6th AGM held on 31 October 2026 via VC/OAVM. The AGM covered routine items, director and auditor appointments, and an IPO objects variation.
Sotac Pharmaceuticals Annual General Meeting
Sotac's EGM sought shareholder approval to raise authorised share capital from Rs.11.5 crore to Rs.15 crore. The video-conference meeting had one resolution.
Jhaveri Credits & Capital Annual General Meeting
Jhaveri Credits and Capital disclosed postal ballot voting results and the scrutinizer's report. Shareholders approved a change of the main object clause and a change of company name.
Aarti Industries Annual General Meeting
Aarti Industries shareholders held an EGM on October 31, 2026 and considered a special resolution. The resolution enables raising up to Rs. 1,000 crore through QIP, private placement or preferential issue, in one or more tranches.
Raymond Annual General Meeting
Raymond seeks shareholder approval via postal ballot to rename itself Raymond Aerospace, Defence & Engineering Limited. E-voting runs November 1 to 30, 2026.
Shriram Finance Annual General Meeting
Shriram Finance sent a postal ballot notice seeking approval to issue up to Rs.35,000 Crore of private placement debentures. Voting runs 31 October to 29 November 2026.
- Value
- ₹35,000 Cr
- Execution
- One year from the date of passing of the resolution